GlassScriptPhysician profile
Catherine L Mcgee
NPI 1699074401
$2,174.28
in general payments reported to CMS, 2019-2025
17 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $111 · 2021: $60.83 · 2022: $166 · 2023: $85.15 · 2024: $516 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $828.59 | 2019 | |
| Abbvie INC. | $271.34 | 2024-2025 | |
| Polarityte, INC. | $229.38 | 2019 | |
| Tela Bio, INC. | $222.60 | 2024 | Ovitex 2s |
| Smith+Nephew, INC. | $194.50 | 2020-2023 | Stravix, Grafix Pl |
| Allergan, INC. | $85.85 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $54.68 | 2025 | |
| Galderma Laboratories, L.P. | $40.67 | 2023 | Dysport |
| Polynovo North America LLC | $38.83 | 2024 | Novosorb Btm |
| Mentor Worldwide LLC | $38.06 | 2022 | |
| Kerecis Limited | $28.92 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Pacira Pharmaceuticals Incorporated | $28.37 | 2024 | Exparel |
| Motiva USA, LLC | $26.40 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $25.40 | 2023 | Seglentis |
| Revance Therapeutics, INC. | $22.08 | 2024 | Daxxify |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $21.22 | 2021 | |
| Tactile Systems Technology INC | $17.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.